Back to results
US 2008/0269233 A1Published application
Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
OwnerMark David Andrews, Alan Daniel Brown +2inventors
InventorsMark David Andrews, Alan Daniel Brown, David Sebastien, Mark Ian Lansdell
Life of this patent
Estimating the term…
Abstract
The present invention relates to a class of compounds of general formula (I) and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R6, R7 and R10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
Claims14
A compound of formula (I):
- wherein:
- n is 1 or 2;
- R6 is selected from H, C1-C6alkyl, C3-C8cycloalkyl, aryl, heterocyclyl, heteroaryl, C(O)C1-C6alkyl, CO2C1-C6alkyl, wherein each of said moieties is optionally substituted with one or more substituents independently selected from halo, CN, OH, ═O, NH2, NHCH3, N(CH3)2, C1-C4alkyl and C1-C4alkoxy;
- R7 is selected from pyridinyl and phenyl, wherein said pyridinyl or said phenyl is optionally substituted by 1-3 groups independently selected from halo, CN, CF3, OCF3, OC1-C4alkyl and C1-C4alkyl;
- R10 is a substituted piperidine group of formula (II):
- wherein
- R1 and R4 are each independently selected from H, C1-C4alkyl, OH, O(C1-C4alkyl), CH2OCH3 and NR8R9;
- R2 is selected from H, OH, OC1-C4alkyl and NR8R9;
- R3 is selected from aryl or heteroaryl, wherein said moieties are optionally substituted with one or more substituents independently selected from halo, CN, CF3, OCF3, O(C1-C4alkyl), and C1-C4alkyl;
- R5 is selected from H and C1-C4alkyl;
- R8 is selected from H and C1-C4alkyl, wherein said C1-C4alkyl is optionally substituted with OH or OCH3;
- R9 is selected from H, C1-C4alkyl, SO2C1-C4alkyl, C(O)C1-C4alkyl;
- wherein aryl means a six or ten membered aromatic hydrocarbon ring which is optionally fused to another six or ten membered aromatic hydrocarbon ring;
- wherein heteroaryl means a 5 or 6 membered aromatic ring, containing from 1 to 4 heteroatoms, said heteroatoms each independently selected from O, S and N, wherein said aromatic ring may be optionally fused to an aryl or second, non-fused, aromatic heterocyclic ring;
- wherein heterocyclyl means a 4 to 7 membered saturated or partially saturated ring, containing from 1 to 2 heteroatoms each independently selected from O, S and N;
- wherein halo means Cl, F, Br or I;
- and pharmaceutically acceptable salts, hydrate, solvates, polymorphs and prodrugs thereof, with the provisos that:
- R1, R4 and R5 are not all simultaneously H;
- when R1 is methyl and R4 is H, then R5 is not methyl;
- when R4 is methyl and R5 is H, then R1 is not methyl;
- and
- when R5 is methyl and R4 is H, then R1 is not methyl.
19 more elements
Dependencies are inferred from the claim text.